Lido Advisors’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$103K Buy
+1,200
New +$105K ﹤0.01% 2035
2026
Q1
Sell
-1,200
Closed -$108K 2155
2025
Q4
$108K Hold
1,200
﹤0.01% 1845
2025
Q3
$118K Hold
1,200
﹤0.01% 1742
2025
Q2
$109K Buy
+1,200
New +$116K ﹤0.01% 1584
2024
Q4
Sell
-1,200
Closed -$130K 1618
2024
Q3
$130K Hold
1,200
﹤0.01% 1383
2024
Q2
$130K Hold
1,200
﹤0.01% 1328
2024
Q1
$158K Hold
1,200
﹤0.01% 1288
2023
Q4
$146K Hold
1,200
﹤0.01% 1263
2023
Q3
$135K Hold
1,200
﹤0.01% 1120
2023
Q2
$175K Hold
1,200
﹤0.01% 1110
2023
Q1
$155K Buy
+1,200
New +$151K ﹤0.01% 1043
2022
Q2
Sell
-1,800
Closed -$230K 1081
2022
Q1
$230K Buy
+1,800
New +$217K ﹤0.01% 909

Other funds holding ZBH

Lido Advisors's ZBH Position: Q2 2026 in Review

Lido Advisors reduced its Zimmer Biomet (ZBH) stake by 2% in Q2 2026, selling an estimated $566K and leaving 317,049 shares worth $27.4M. The position accounts for 0.07% of the portfolio, ranked #177.

Lido Advisors first reported a position in ZBH in Q3 2020 and has held it in 22 quarters since. The position peaked at $31M in Q3 2025. 909 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

  • Lido Advisors held 317,049 shares of Zimmer Biomet worth $27.4M as of Q2 2026.
  • Lido Advisors sold 6,458 Zimmer Biomet shares in Q2 2026, an estimated $566K.
  • Zimmer Biomet made up 0.07% of Lido Advisors's portfolio in Q2 2026, its #177 holding.
  • Lido Advisors first reported a position in Zimmer Biomet in Q3 2020 and has held it in 22 quarters since.
  • Lido Advisors's Zimmer Biomet position peaked at $31M in Q3 2025.
  • 909 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on Lido Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.